Thu, December 1, 2022

Corinne Jenkins Initiated (ACRS) at Strong Buy and Held Target at $25 on, Dec 1st, 2022

Corinne Jenkins of Goldman Sachs, Initiated "Aclaris Therapeutics, Inc." (ACRS) at Strong Buy and Held Target at $25 on, Dec 1st, 2022.

Corinne has made no other calls on ACRS in the last 4 months.



There is 1 other peer that has a rating on ACRS. Out of the 1 peers that are also analyzing ACRS, 0 agree with Corinne's Rating of Hold.



This is the rating of the analyst that currently disagrees with Corinne


  • Julian Harrison of "BTIG" Initiated at Strong Buy and Held Target at $32 on, Thursday, October 6th, 2022